Home › Funds › PSP Research LLC › KRYS

PSP Research LLC position in KRYS

KRYSTAL BIOTECH INC · Health Care

PSP Research LLC reported holding 692 shares of KRYS (KRYSTAL BIOTECH INC) in its Q3 2026 13F filing — a position valued at US$230K, representing 0.16% of its reported portfolio and ranking #28 among its reported holdings. PSP Research LLC has disclosed KRYS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)692 sh
Reported value held$230.13K
Portfolio Weight0.16%
First reportedQ2 2026
Last changeHold
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How PSP Research LLC's KRYS position evolved

PSP Research LLC first disclosed a stake in KRYS in Q2 2026 at 692 shares (US$257K). Across 2 filings, PSP Research LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 692 shares valued at US$230K.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 692 $257.20K New
Q3 2026 692 $230.13K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KRYS and 13F data

KRYS (KRYSTAL BIOTECH INC) is a Health Care company. 49 other funds we track also report a position in KRYS — the largest reported positions include Avoro Capital Advisors LLC (US$1.07B), Soleus Capital Management, L.P. (US$349.1M), Hood River Capital Management LLC (US$246.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KRYS

All KRYS fund holders →

FAQ

How long has PSP Research LLC held KRYS?

PSP Research LLC has disclosed KRYS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is PSP Research LLC's current position in KRYS?

As of Q3 2026, PSP Research LLC holds 692 shares of KRYS (KRYSTAL BIOTECH INC), valued at $230.13K, representing 0.16% of its reported portfolio and ranking #28.

Has PSP Research LLC been buying or selling KRYS?

In the latest 13F filing (Q3 2026), PSP Research LLC held unchanged its position in KRYS.

Which other funds hold KRYS?

Other major institutional holders of KRYS include Avoro Capital Advisors LLC, Soleus Capital Management, L.P., Hood River Capital Management LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.